Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial

Lancet Neurology
Ivo N van SchaikM Vermeulen

Abstract

Pulsed high-dose dexamethasone induced long-lasting remission in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in a pilot study. The PREDICT study aimed to compare remission rates in patients with CIDP treated with high-dose dexamethasone with rates in patients treated with standard oral prednisolone. In eight neuromuscular centres in the Netherlands and one in the UK, patients aged 18 years or older who had newly diagnosed definite or probable CIDP were randomly assigned to a treatment regimen of either pulsed high-dose dexamethasone or standard oral prednisolone. Randomisation was done with a random number generator. The primary outcome measure was remission at 12 months, defined as improvement of at least three points on the Rivermead mobility index and improvement of at least one point on the inflammatory neuropathy cause and treatment disability scale. Analysis was by intention to treat. This trial is registered with Current Controlled Trials, number ISRCTN07779236. Between December, 2003, and December, 2008, 40 patients were treated: 24 received dexamethasone and 16 received prednisolone. At 12 months, 16 patients were in remission: ten in the dexamethasone group and six in the prednisolon...Continue Reading

References

Jul 13, 1999·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·J L Fernández-TorreJ Berciano
Jun 5, 2002·Current Opinion in Neurology·John D Pollard
Dec 6, 2003·The New England Journal of Medicine·Bertrand Godeau, Philippe Bierling
Jan 7, 2005·Clinical Pharmacokinetics·David CzockUlla Häussler
Dec 20, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·S KuwabaraT Hattori
May 15, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·A ChiòUNKNOWN PARCIDP
Aug 7, 2007·International Journal of Epidemiology·David L Sackett
Dec 1, 1999·Journal of Clinical Neuromuscular Disease·Z Simmons

❮ Previous
Next ❯

Citations

Jun 19, 2013·Journal of Neurology·Pierre LozeronNathalie Kubis
Jan 19, 2011·Current Treatment Options in Neurology·Glenn Lopate, Alan Pestronk
Aug 17, 2011·Nature Reviews. Neurology·Marinos C Dalakas, UNKNOWN Medscape
May 4, 2011·Nature Reviews. Neurology·Hans-Peter HartungHugh J Willison
Jun 23, 2011·Therapeutic Advances in Neurological Disorders·Min-Suk YoonRalf Gold
Nov 10, 2012·Therapeutic Advances in Neurological Disorders·Kenneth C Gorson
Jul 20, 2012·Continuum : Lifelong Learning in Neurology·Yuen T So
Jul 21, 2010·Neurology India·Kamakshi PatelSuraj Ashok Muley
Apr 9, 2014·BMC Neurology·Filip EftimovUNKNOWN PREDICT study group
Jul 2, 2014·Nature Reviews. Neurology·Norman Latov
Sep 10, 2014·Revue neurologique·R Guimarães-CostaJ-M Léger
May 26, 2015·Journal of Neuroimmunology·Juliane KlehmetChristian Meisel
Nov 26, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jean-Marc LégerCristina Muntean
Apr 30, 2013·La Presse médicale·Peter Y K Van den Bergh, Yusuf A Rajabally
May 7, 2013·Neurologic Clinics·Kenneth C Gorson, Jonathan Katz
May 15, 2012·Lancet Neurology·Ivo N van Schaik
May 31, 2011·Autoimmunity Reviews·Bernd C KieseierGerd Meyer Zu Hörste
Jun 27, 2015·Journal of the Peripheral Nervous System : JPNS·Els K VanhoutteUNKNOWN PeriNomS Study Group
Sep 14, 2013·Journal of the Peripheral Nervous System : JPNS·Petrica-Adrian PanaiteThierry Kuntzer
Mar 13, 2014·Journal of the Peripheral Nervous System : JPNS·Eduardo Nobile-Orazio
Nov 26, 2015·Neural Regeneration Research·Yusuf A Rajabally
Jul 24, 2015·Current Opinion in Neurology·Eduardo Nobile-Orazio, Francesca Gallia
Feb 3, 2015·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·B S BerthonL G Wood
Jul 17, 2015·Neurology·Jeffrey A Allen, Richard A Lewis
Sep 24, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Eduardo Nobile-OrazioUNKNOWN IMC Trial Group
Apr 18, 2015·BMC Neurology·Elisabeth ChroniPanagiotis Papathanasopoulos
May 27, 2015·Current Neurology and Neuroscience Reports·Inna Kleyman, Thomas H Brannagan
Jan 8, 2015·Frontiers in Immunology·Jacqueline KerrHans-Hartmut Peter
Jul 15, 2016·Nature Reviews. Rheumatology·Alain SarauxValérie Devauchelle-Pensec
Jul 31, 2016·Der Nervenarzt·G Stoll, K Reiners
Jun 10, 2017·Expert Review of Neurotherapeutics·Eduardo Nobile-OrazioMariangela Bianco

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.